Ann Barbier
Director/Board Member chez PIERIS PHARMACEUTICALS, INC.
Fortune : - $ au 31/03/2024
Profil
Ann Barbier is an Independent Director at Pieris Pharmaceuticals, Inc. and the Chief Medical Officer at Camp4 Therapeutics Corp.
She previously worked as the Senior Director-Medical at Shire Human Genetic Therapies, Inc. from 2007 to 2011, Vice President-Clinical Development at Agios Pharmaceuticals, Inc. from 2015 to 2017, Chief Medical Officer at Translate Bio, Inc. from 2017 to 2021, and Global Lead-Clinical Development at Shire Pharmaceuticals, Inc. from 2014 to 2015.
Dr. Barbier holds a doctorate degree from Ghent University and a graduate degree from Université Libre de Bruxelles.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 21/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Ann Barbier
| Sociétés | Poste | Début |
|---|---|---|
| PIERIS PHARMACEUTICALS, INC. | Director/Board Member | 25/04/2018 |
Camp4 Therapeutics Corp.
 Camp4 Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Camp4 Therapeutics Corp. operates as a biotechnology company. The firm discovers a treatment option for patients. The company was founded by Paulina Hill and Leonard Zon on May 20, 2016 and is headquartered in Cambridge, the United Kingdom. | Chief Tech/Sci/R&D Officer | 14/03/2022 |
Anciens postes connus de Ann Barbier
| Sociétés | Poste | Fin |
|---|---|---|
| TRANSLATE BIO, INC. | Chief Tech/Sci/R&D Officer | 14/09/2021 |
| AGIOS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/10/2017 |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Chief Tech/Sci/R&D Officer | 01/05/2015 |
Shire Human Genetic Therapies, Inc.
 Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Corporate Officer/Principal | 01/02/2011 |
Formation de Ann Barbier
| Ghent University | Doctorate Degree |
| Université Libre de Bruxelles | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| AGIOS PHARMACEUTICALS, INC. | Health Technology |
| PIERIS PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Translate Bio, Inc.
 Translate Bio, Inc. BiotechnologyHealth Technology Translate Bio, Inc. engages in the research and development of therapeutic drugs. It focuses on developing medicines to treat diseases caused by protein or gene dysfunction. Its lead product candidate, MRT5005 is designed for the treatment of cystic fibrosis. The company was founded by Arthur M. Krieg and Jeannie T. Lee in 2011 and is headquartered in Lexington, MA. | Health Technology |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Health Technology |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Health Technology |
Camp4 Therapeutics Corp.
Camp4 Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Camp4 Therapeutics Corp. operates as a biotechnology company. The firm discovers a treatment option for patients. The company was founded by Paulina Hill and Leonard Zon on May 20, 2016 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
